Medical Properties Trust's $2.4 billion financing package pushes major debt maturities out to 2032—eliminating immediate refinancing risk at the expense of higher interest costs. A clear look at the $0.057 per share quarterly FFO headwind from the new 9.25% Senior Notes and how upcoming rent ramp-ups aim to cushion the impact. The $1.1 billion asset sale pipeline is achieving prices substantially higher than original cost bases.
Medical Properties Trust, Inc. (MPT) Q2 2026 Earnings Call Transcript
Medical Properties Trust NYSE: MPT said it has launched a two-step refinancing plan intended to address its 2026 and 2027 debt maturities, while reporting second-quarter normalized funds from operations of $0.15 per share and describing stable performance across much of its hospital portfolio.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Curtis Ellergodt Rothschild Investment LLC | 14,328 | $69,554.31 | $66,768.48 | -$2,785.83 | -4.01% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 117,527 | $542,970 | $552,376.9 | $9,406.9 | 1.73% |
| ABB Alexander Bjornager Bonde Danske Bank A/S | 400 | $2,000 | $1,888 | -$112 | -5.6% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 7,565 | $37,758.74 | $30,411.3 | -$7,347.44 | -19.46% |
| NA Nizar Araji National Bank Of Canada /FI/ | 71,220 | $1.07M | $336,158.4 | -$729,670.29 | -68.46% |